Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Research area

Phase 1 Lung Cancer trials

Lung cancer research looks at investigational medications, radiation approaches, and screening methods across different types and stages of lung cancer. If you are wondering whether a study may be a fit for you, we at Phase 1 Cancer Trials can help you find out.

Updated

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Phase 1 lung cancer studies in numbers

Phase 1 lung cancer studies recruiting in the U.S.
330
states with a study site
42
studies that accept healthy volunteers
6

Source: ClinicalTrials.gov. Data processed .

Find Phase 1 lung cancer studies by state

These states have the most studies recruiting right now.

Phase 1 lung cancer studies recruiting now

As of November 17, 2026, 330 Phase 1 lung cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry. This is what they have in common.

What they test

  • medications296
  • biologics such as vaccines or antibodies60
  • procedures26
  • radiation19
  • other approaches12

A study can test more than one.

Main purpose

  • treating a condition318
  • diagnosis7
  • prevention2
  • basic science1

Phase

  • Early Phase 15
  • Phase 1173
  • Phase 1/2152

Who runs them

  • industry235
  • university, hospital or other84
  • government11

Who they enroll

  • adults (18 to 64)328
  • older adults (65 and over)326
  • children (under 18)9

6 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 330 studies.

Recently updated Phase 1 lung cancer studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Vivace Therapeutics, Inc
    Recruiting in
    Arlington, VA · Boston, MA · Chicago, IL · and 5 more U.S. locations
    Registry record
    NCT04665206 · updated
  2. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Recruiting in
    Boston, MA · Cleveland, OH · Durham, NC · and 14 more U.S. locations
    Registry record
    NCT05786924 · updated
  3. Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    LG Chem
    Recruiting in
    Fairfax, VA
    Registry record
    NCT06332755 · updated
  4. A Study of VET3-TGI in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    KaliVir Immunotherapeutics
    Recruiting in
    Dallas, TX · Houston, TX · Los Angeles, CA · and 4 more U.S. locations
    Registry record
    NCT06444815 · updated
  5. A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    EpiBiologics
    Recruiting in
    East Brunswick, NJ · Houston, TX · Lake Success, NY · and 3 more U.S. locations
    Registry record
    NCT07462377 · updated
  6. A Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SystImmune Inc.
    Recruiting in
    Houston, TX
    Registry record
    NCT07940881 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in the United States on ClinicalTrials.gov.

What lung cancer studies look at

Lung cancer studies are each built around a single question. One may test an investigational medication, another a radiation approach, another a method of screening, and between them they cover different types and stages of lung cancer. Your part in a study, or the part of the person you care for, therefore changes from one study to the next.

We describe everything under test in a study as investigational. A study is run because the risks, and how well the thing being tested works, are not yet fully understood. Researchers are still finding that out.

Who may be able to take part

No two studies ask for exactly the same things. The list for one study may cover your age, the medications you take now, your past health, and how lung cancer affects you. Some studies are also open to people without lung cancer.

Eligibility is for the study team to check, not you. They do this at a screening visit, whether you are asking for yourself or for someone you care for. Our guide to eligibility and screening explains the process.

What taking part usually involves

  1. A first conversation

    Your first conversation is with a coordinator. Nothing else takes place until they have given you a general outline of the study and you have had your questions answered.

  2. Informed consent

    Written information comes next. In it the study team sets out every detail, known risks included. Whether to agree is your decision.

  3. Screening

    The team asks about your health and runs tests. The results tell them, and you, if this study is a suitable fit. Being screened does not always lead to taking part.

  4. Study visits

    Once you are in the study, visits are scheduled and the team uses them to keep track of your health. Leaving is your choice, and you can make it at any point.

Questions about Phase 1 lung cancer studies

Do I need a diagnosis to join a study about lung cancer?

The answer changes from one study to the next. Certain trials ask that your diagnosis be confirmed. Others assess you themselves while screening is under way. Once you are in contact with the study team, they will let you know what applies to you.

Would I have to change the care I receive now?

Please leave your current care as it is and do not adjust it on your own. Whether that care can carry on during a study differs: it can in some and cannot in others. It is the study doctor who reviews your care with you. Before deciding, you are free to speak with your own doctor too.

Is there a cost to take part?

As a general rule, participants do not pay for the visits, tests, or medication that are part of a study. Our page on costs goes into more detail.

Ask about Phase 1 lung cancer studies

We need only a few details about you or the person you care for. After that a coordinator gets in touch, and making an enquiry leaves you under no obligation.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call